+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Medical Nanobiotechnology. Nanomedicine for Repair, Regeneration, Remodelling, and Recovery. Woodhead Publishing Series in Biomaterials

  • Book

  • December 2024
  • Elsevier Science and Technology
  • ID: 5954967

Medical Nanobiotechnology: Nanomedicine for Repair, Regeneration, Remodelling, and Recovery thoroughly reviews the potential of functionalized biomaterials as ideal candidates for nanomedicine. The book covers advances in the development of nanotheranostic agents that can simultaneously help in both effective therapy and rapid diagnosis. A range of materials is covered, including their fabrication, characterization and assessment, as well as their functionalization and incorporation into implants and medical devices. Clinical aspects and challenges are discussed, helping bridge the gap between laboratory research and the translational impact as nanomedicine begins to develop point-of-care customized therapy. This book is an interdisciplinary reference for researchers and R&D groups interested in the development of novel nanobiomaterials for therapeutic applications.

Table of Contents

  1. Biomaterials and bioengineering: A detailed overview
  2. Nanostructures for diagnosis and biosensing
  3. Engineered materials for improving various imaging modalities
  4. Enzyme-functionalized nanodrugs
  5. Metal and metal oxide-based nanostructures for drug delivery
  6. Carbon-based and polymeric nanostructures for the delivery of therapeutics: Recent advancements and future prospects
  7. Targeted delivery strategies for nanomedicine
  8. Advanced materials for triggered release of drugs
  9. Nanozyme-associated toxicity and regulation
  10. Novel materials for 3D and 4D bioprinting of organs and tissues
  11. Nanomedicine in tissue regeneration
  12. Nanomedicine and biomaterials for wound healing and repair applications
  13. Recent advancements in nanobiomaterials for the management of ischemic diseases
  14. Application of nanobiomaterials in tissue engineering, repair, and cell remodeling
  15. Immunomodulation strategies of nanobiomaterials by modulating surface chemistry and physical properties
  16. Developing smart medical implants using functionalized carbon nanostructures
  17. Graphdiyne-based biomaterials for biosensor and imaging applications
  18. Surface-functionalized magnetic nanomaterials for the diagnosis and targeted therapy against cancer
  19. Nanohybrids for the detection and control of infectious diseases
  20. Polymer-based formulations against metastatic non-small-cell lung cancer: A nanotherapeutic approach

Authors

Sougata Ghosh Department of Microbiology, School of Science, RK University, Rajkot, Gujarat, India; Department of Physics, Faculty of Science, Kasetsart University, Bangkok, Thailand. Dr. Sougata Ghosh is an Associate Professor in the Department of Microbiology, School of Science, RK University, India. He obtained his B.Sc., M.Sc. and Ph.D. in Microbiology from Savitribai Phule Pune University, India. He is also Visiting Professor at the Department of Physics, Faculty of Science, Kasetsart University, Bangkok, Thailand and Department of Chemical Engineering, Northeastern University, Boston, USA. He was principal investigator of the Department of Biotechnology (DBT), Government of India funded Foldscope Research Project. He has filed seven patents on novel nanodrugs and published more than seventy highly cited research articles in various international journals such as the International Journal of Nanomedicine, Journal of Nanobiotechnology, Journal of Nanomaterials, Journal of Nanoscience and Nanotechnology. He has edited ten books and contributed to one hundred fifty book chapters. As speaker he has addressed numerous international conferences, the most notable being ICMAR 2023 at Cebu Normal University, Philippines, 1st JICEST-2023 at University of Jambi, Indonesia, IJAS-2019 at Harvard University, USA; ITNANO, Northeastern University, USA; ASM Biodefense, Washington D.C. USA; Nano-Bio-Med-2013, Italy and BioMicroWorld-2013, Spain. He is a reviewer for various reputed journals such as Nanoscale, Journal of Photochemistry & Photobiology, B: Biology, Journal of Diabetes Research, International Journal of Advances in Engineering Research, International Journal of Research in Science and Technology, Chemotherapy Research and Practice, Journal of Nanomedicine & Biotherapeutic Discovery, Journal of Nanomedicine and Nanotechnology, Applied Nanoscience and Arabian Journal of Chemistry. He is a life member of the Association of Microbiologists of India (AMI). His area of research consists of but is not limited to nanomedicine, microbial metabolism, bioprospecting, bioremediation, biofilms, cancer and diabetes. Thomas J. Webster School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin, China; School of Engineering, Saveetha University, Chennai, Tamil Nadu, India; Materials Program, Federal University of Piaui, Teresina, Brazil. Thomas J. Webster is a Professor at the School of Health Sciences and Biomedical Engineering, Hebei University of Technology, Tianjin, China. He is also a Visiting Professor at the Center for Biomaterials, Vellore Institute of Technology, Vellore, India and the Department of Materials Science and Engineering, Federal University of Piaui, Brazil. His degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995) and in biomedical engineering from Rensselaer Polytechnic Institute (M.S., 1997; Ph.D., 2000). He has served as a professor at Purdue University (2000-2005), Brown University (2005-2012), and Northeastern University (2012-2021). He was the founding editor-in-chief of the International Journal of Nanomedicine (pioneering the open-access format). Prof. Webster has received numerous honors including: 2012, Fellow, American Institute for Medical and Biological Engineering; 2013, Fellow, Biomedical Engineering Society; 2016, International College of Fellows, Biomaterials Science and Engineering; 2016, Acta Biomaterialia Silver Award; 2019, Overseas Fellow, Royal Society of Medicine (UK); and 2022, Clarivate Most Distinguished Researcher (Top 0.1% in citations). He also served as the President of the U.S. Society For Biomaterials.